Capitainer awarded ISO 13485:2016 as interest grows in qDBS testing for COVID-19 and other challenging applications

Stockholm, November 11, 2020: Capitainer AB, a medtech company committed to making Dried Blood Spot testing universal, is pleased to announce that the company has received the International Organization for Standards (ISO) 13485:2016 certification for its Quality Management System (QMS).

Capitainer’s certification is issued by Lloyds Registar, one of the world’s leading providers of business certification, verification, audit, and training courses. ISO 13485 is designed specifically for medical device companies and commonly regarded as essential for accessing international markets. It comes as Capitainer enters a period of rapid expansion following the signing of key distribution agreements in the US and Europe for its highly accurate qDBS dried blood spot sampling system. Interest is strong across a wide range of challenging applications from therapeutic drug monitoring, genomics anti-doping testing to COVID-19 testing.

Christopher Aulin, CEO of Capitainer commented: “We are delighted to have attained ISO 13485 for our Quality Management System. We are committed to developing the highest quality products at Capitainer and our team has worked hard to achieve this milestone. Both the FDA and EU require a quality system and this award will accelerate commercialisation.”

Capitainer’s qDBS system is designed to enable patients to collect their own volume defined dried blood spot at home. The patented smart chip ensures precise sample volumes of 10ul with low CV, independent of haematocrit. Patients simply place their finger over the inlet port on the qDBS card which automatically fills a microchannel with the required amount and discards any excess. The potential for human error is thus completely eliminated. Subsequently, the blood volume contained in the microchannel automatically transfers to the specimen collection membrane, forming an accurate and high-quality dried blood spot sample, preserved for quantitative bioanalysis. The filled card can then be safely transported to the point of testing without the need for refrigeration or specialised packaging.

Read more news

Swedish medtech start-up Capitainer hires VWR veteran Tom Sölch as COO amid mounting interest in novel qDBS dried blood spot sampling system for COVID-19 testing and other key applications

    Stockholm, September 1, 2020: Swedish medtech start-up Capitainer hires VWR veteran Tom Sölch as COO amid mounting interest in novel qDBS dried blood spot sampling system for COVID-19 testing and other key applications Swedish medtech start-up Capitainer...

Meet us at IATDMCT Congress in Brisbane 16-19/9

    Capitainer participates in (IATDMCT) Congress 2018, 16–19 September 2018 in Brisbane, Australia The 16th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2018) will be held from Sunday 16th to Wednesday 19th...

Meet us at AACC Annual Scientific Meeting

    Capitainer participates in AACC Annual Scientific Meeting July29-August 2, 2018 The 70th AACC Annual Scientific Meeting & Clinical Lab Expo is the largest global scientific conference and tradeshow in the field of laboratory medicine. This is part of...

Capitainer invited speaker at PRINSE’18

    Capitainer was invited speaker in the diagnostics session at PRINSE’18 (the 5th Printed Intelligense Industry Seminar) this year focusing on ”Manufacturing Solutions for Customer Needs and Vision to the Future”, Jan 31- Feb 1, 2018, in Oulu, Finland. The...

Ernst Westman new Chairman of the Board

    The board of directors has elected Mr. Ernst Westman as new Chairman of the Board of Capitainer AB. Mr. Westman has been President and CEO of the listed blood diagnostics Boule Diagnostics AB (publ) between 1994 to 2017 and now takes over the leadership in...

Ta blodprovet själv, KTH magazine

Hjärtpatienten Sigvard sitter hemma i köket och förbereder ett blodprov på sig själv. Efter hjärtattacken för ett halvår sedan behandlas han med den blodförtunnande medicinen Waran för att minska risken för återfall. Ett problem med Waran är att doseringen är väldigt...

Capitainer Featured on KTH Home Page

Capitainer technology is highlighted as a news article on KTH’s first page. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam for further...

Capitainer Selected Best Start-Up

Capitainer was selected best Start-Up at the Nordic Pitch Night event Aug 25 in Silicon Valley, USA Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam for...

Nordic Life Science Days, Sept. 14-15 in Stockholm

Capitainer has been selected to exhibiting at the Nordic Life Science days Sept. 14-15 in Stockholm. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam...

AACC Annual Scientific Meeting & Clinical Lab Expo

Capitainer is presenting their technology at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo Aug 1-4, in Philadelphia, USA. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested...

Brighter Startup Program

Capitainer is attending the Brighter Startup Program, a one week program for Swedish entrepreneurs located in Silicon Valley’s unique and leading innovation and entrepreneurship ecosystem. Read more news Get In Touch   We are currently seeking funding to reach...

Capitainer Exhibits at STING-day

Capitainer is selected as one of few KTH-start-ups to exhibit at the prestigious STING-day on May 28, an investor event gathering Stockholm’s most promising tech start-ups connecting then to VC’s and investors from around the world. Read more news Get In Touch  ...

Clinical Chemistry Meeting in Malmö

Capitainer is presenting at the Swedish Clinical Chemistry spring meeting in Malmö May 11-13, Sweden. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam...

KTH’s President’s innovation event

Capitainer is selected to present during KTH’s President’s innovation event. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam for further...

Capitainer Awarded 2 MSEK

Capitainer is awarded 2 MSEK in seed funding from the Swedish Innovation Agency VINNOVA in the competitive ViNNVerifiering program, a program in designed to promote the best academic start-up cases. Read more news Get In Touch   We are currently seeking funding...